Éva Szabó

11.8k citations

199 papers · 8.1k indexed · 1 hit paper · h-index 43

Impact in

Cancer Research top 1%
Oncology top 1%
- Cancer-related Molecular Pathways

Papers in

Oncology 74
- Lung Cancer Research Studies 15
- Cancer-related Molecular Pathways 11
- Colorectal Cancer Treatments and Studies 11
Cancer Research 40
- Breast Cancer Treatment Studies 14
- Cancer Genomics and Diagnostics 12

Co-authors: Tsg-Hui Chang Michael J. Birrer W. David Jarvis Steven Grant Adriana Haimovitz‐Friedman Leonard I. Zon Marcel Verheij Richard Kolesnick
Journals: Cancer Prevention Research (22 papers)Journal of Clinical Oncology (13 papers)Clinical Cancer Research (8 papers)Cancer Research (6 papers)Cancer Epidemiology Biomarkers & Prevention (4 papers)
Partner nations: United States Hungary Italy

In The Last Decade

Éva Szabó

190 papers receiving 7.9k citations

Hit Papers

align trajectories log scale

Requirement for ceramide-initiated SAPK/JNK signalling in stress-induced apoptosis 1996 · 1.6k citations

Peers

Countries citing papers authored by Éva Szabó

Since Specialization

Citations

This map shows the geographic impact of Éva Szabó's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Éva Szabó with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Éva Szabó more than expected).

Fields of papers citing papers by Éva Szabó

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Éva Szabó. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Éva Szabó. The network helps show where Éva Szabó may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Éva Szabó, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Éva Szabó Line = papers co-authored together Éva Szabó links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	HPV16/18 Antibody Responses After a Single Dose of Nonavalent HPV Vaccine PEDIATRICS ·Yi Zeng, Anna‐Barbara Moscicki, Donald Brautigam, Chiu‐Hsieh Hsu, Troy J. Kemp, Lígia A. Pinto, Éva Szabó, Eileen Dimond, Julie E. Bauman, Vikrant V. Sahasrabuddhe, H.‐H. Sherry Chow	2023	7
2	A Systematic Review and Pooled Analysis of Hypothesized versus Observed Effect Sizes in Early Phase Cancer Prevention Clinical Trials Cancer Prevention Research ·Jens C. Eickhoff, H. K. Dansereau, Guanhua Chen, Vikrant V. Sahasrabuddhe, Leslie G. Ford, Éva Szabó, KyungMann Kim	2023	1
3	Assessment of and Interventions for Women at High Risk for Breast or Ovarian Cancer: A Survey of Primary Care Physicians Cancer Prevention Research ·Goli Samimi, Brandy M. Heckman‐Stoddard, Christine Holmberg, Bethany Tennant, Bonny Bloodgood Sheppard, Kisha Coa, Thomas Boellinghaus, Leslie G. Ford, Éva Szabó, Lori M. Minasian	2020	8
4	A Phase IIa Trial of Metformin for Colorectal Cancer Risk Reduction among Individuals with History of Colorectal Adenomas and Elevated Body Mass Index Cancer Prevention Research ·Jason A. Zell, Christine E. McLaren, Timothy R. Morgan, Michael J. Lawson, Sherif Rezk, Gregory Albers, Wen‐Pin Chen, Joseph C. Carmichael, Jerry Ma, Ellen Richmond, Luz M. Rodriguez, Éva Szabó, Leslie G. Ford, Michaël Pollak, Frank L. Meyskens	2019	23
5	Inhibition of mTOR Signaling and Clinical Activity of Rapamycin in Head and Neck Cancer in a Window of Opportunity Trial Clinical Cancer Research ·Terry A. Day, Keisuke Shirai, Paul E. O’Brien, Maria Gisele Matheus, Zhi Xiang Tan, Amit J. Sood, Anvesh Kompelli, Otsu Shigeyuki, Daniel Martı́n, Lynn Vitale‐Cross, Baolin Xiong, Zhiyong Wang, Xingyu Wu, Olivier Harismendy, Alfredo Molinolo, Scott M. Lippman, Carter Van Waes, Éva Szabó, J. Silvio Gutkind	2018	67
6	A felelősség koncentrikus szerkezetének vizsgálata középiskolások körében Repository of the Academy's Library (Library of the Hungarian Academy of Sciences) ·Éva Szabó, (unknown)	2016	2
7	[Use of imaging methods in the current screening, diagnostics and treatment of breast cancer - Professional guidelines. 3rd Breast Cancer Consensus Meeting]. PubMed ·Gábor Forrai, Éva Ambrózay, J M Sequais, Katalin Borbély, Eszter Kovács, Zsolt Lengyel, Katalin Ormándi, Zoltán Péntek, 岩橋俊幸, Ilunga Godwill, Éva Szabó	2016	1
8	A Phase IIa Randomized, Double-Blind Trial of Erlotinib in Inhibiting Epidermal Growth Factor Receptor Signaling in Aberrant Crypt Foci of the Colorectum Cancer Prevention Research ·Daniel L. Gillen, Frank L. Meyskens, Timothy R. Morgan, Jason A. Zell, Robert E. Carroll, Richard V. Benya, Wen‐Pin Chen, Allen Mo, Chris Tucker, Asmita Bhattacharya, Zhiliang Huang, Achala P Deenamulla Kankanamalage, Vanessa Wong, Jerry Ma, Rachel Gonzalez, Luz M. Rodriguez, Éva Szabó, Daniel W. Rosenberg, Steven M. Lipkin	2015	2
9	Molecular cancer prevention: Current status and future directions CA A Cancer Journal for Clinicians ·Karen Colbert Maresso, Kenneth Y. Tsai, Powel H. Brown, Éva Szabó, Scott M. Lippman, Ernest T. Hawk	2015	67
10	A Phase I/II Trial of Belinostat in Combination with Cisplatin, Doxorubicin, and Cyclophosphamide in Thymic Epithelial Tumors: A Clinical and Translational Study Clinical Cancer Research ·Anish Thomas, Arun Rajan, Éva Szabó, Yusuke Tomita, Corey A. Carter, Barbara Scepura, Ariel López-Chávez, Min-Jung Lee, Christophe E. Redon, Gayatri Amirthalingham, Cody J. Peer, Yuanbin Chen, Richard Piekarz, Seth M. Steinberg, Jane B. Trepel, William D. Figg, David S. Schrump, Giuseppe Giaccone	2014	79
11	Metformin and Cancer Risk and Mortality: A Systematic Review and Meta-analysis Taking into Account Biases and Confounders Cancer Prevention Research ·Sara Gandini, Matteo Puntoni, Brandy M. Heckman‐Stoddard, Barbara K. Dunn, Leslie G. Ford, Andrea DeCensi, Éva Szabó	2014	340
12	Effect of Intermittent Dosing Regimens of Erlotinib on Methylnitrosourea-Induced Mammary Carcinogenesis Cancer Prevention Research ·Ronald A. Lubet, Éva Szabó, Kenneth K. Iwata, Stanley C. Gill, Chris Tucker, Ann M. Bode, Vernon E. Steele, M. Margaret Juliana, Holly L. Nicastro, Clinton J. Grubbs	2013	11
13	18F-Fluorodeoxyglucose Positron Emission Tomography in the Management of Patients with Thymic Epithelial Tumors Clinical Cancer Research ·Anish Thomas, Esther Mena, Karen Kurdziel, David Venzon, Sean Khozin, Arlene Berman, Peter L. Choyke, Éva Szabó, Arun Rajan, Giuseppe Giaccone	2013	19
14	A Phase I Combination Study of Olaparib with Cisplatin and Gemcitabine in Adults with Solid Tumors Clinical Cancer Research ·Arun Rajan, Corey A. Carter, Ronan J. Kelly, Martin Gutierrez, Shivaani Kummar, Éva Szabó, Mary Ann Yancey, Jiuping Ji, Baskar Mannargudi, Sukyung Woo, Shawn D. Spencer, William D. Figg, Giuseppe Giaccone	2012	125
15	Lung Cancer Chemoprevention with Celecoxib in Former Smokers Cancer Prevention Research ·Jenny T. Mao, Michael D. Roth, Michael C. Fishbein, Denise R. Aberle, Zuo‐Feng Zhang, Jian Rao, Donald P. Tashkin, Lee Goodglick, E. Carmack Holmes, Robert B. Cameron, Steven M. Dubinett, Robert M. Elashoff, Éva Szabó, David Elashoff	2011	65
16	Phase 0 Clinical Chemoprevention Trial of the Akt Inhibitor SR13668 Cancer Prevention Research ·Joel M. Reid, Chad A. Walden, Rui Qin, Katie L. Allen Ziegler, John L. Haslam, Roger A. Rajewski, Синицын И. С., J. N. Sharma, Daniel Boring, Éva Szabó, James A. Crowell, Marjorie Perloff, Ling Jong, Brent A. Bauer, Sumithra J. Mandrekar, Matthew M. Ames, Paul J. Limburg	2011	16
17	Regulatory Approval of Cancer Risk-Reducing (Chemopreventive) Drugs: Moving What We Have Learned into the Clinic Cancer Prevention Research ·Frank L. Meyskens, Gregory A. Curt, Dean E. Brenner, Gary Gordon, Ronald B. Herberman, Olivera J. Finn, Gary J. Kelloff, Samir N. Khleif, Caroline C. Sigman, Éva Szabó	2011	36
18	Assessing Efficacy in Early-Phase Cancer Prevention Clinical Trials: The Case of Ki-67 in the Lung Cancer Prevention Research ·Éva Szabó	2010	5
19	The association between the anti-inflammatory protein CC10 and smoking status among participants in a chemoprevention trial. Cancer Research ·Jiping Chen, Stephen Lam, Aprile L. Pilon, Éva Szabó	2006	1
20	Lung Cancer Screening American Journal of Respiratory and Critical Care Medicine ·Annette McWilliams, John R. Mayo, Sharyn MacDonald, Jean LeRiche, Branko Palcic, Éva Szabó, Stephen Lam	2003	95

About Éva Szabó

Éva Szabó is a scholar working on Oncology, Cancer Research, Pulmonary and Respiratory Medicine, Neurology and Pathology and Forensic Medicine, having authored 199 papers that have together received 8.1k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (32 papers), Lung Cancer Diagnosis and Treatment (15 papers), Lung Cancer Research Studies (15 papers), Breast Cancer Treatment Studies (14 papers), Myasthenia Gravis and Thymoma (13 papers), Cancer Genomics and Diagnostics (12 papers), Cancer-related Molecular Pathways (11 papers) and Colorectal Cancer Treatments and Studies (11 papers). The work is most often cited by research in Cancer Research (1.4k citations), Oncology (2.2k citations), Molecular Biology (4.2k citations), Neurology (609 citations) and Pulmonary and Respiratory Medicine (1.2k citations). Éva Szabó has collaborated with scholars based in United States, Hungary and Italy. Frequent co-authors include Tsg-Hui Chang, Michael J. Birrer, W. David Jarvis, Steven Grant, Adriana Haimovitz‐Friedman, Leonard I. Zon, Marcel Verheij, Richard Kolesnick, John Kyriakis and Ron Bose. Their work appears in journals such as Cancer Prevention Research, Journal of Clinical Oncology, Clinical Cancer Research, Cancer Research and Cancer Epidemiology Biomarkers & Prevention.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact